Home > Balance Sheet > INDO US BIOTECH

INDO US BIOTECH
Contingent Liabilities

    Back to Balance Sheet
COMMUNITY POLL
for INDO US BIOTECH
Please provide your vote to see the results

INDO US BIOTECH Last 5 Year Contingent Liabilities History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
Contingent Liabilities ₹0.98 Cr₹0.95 Cr₹0.67 Cr₹0.59 Cr-

What is the latest Contingent Liabilities ratio of INDO US BIOTECH ?

The latest Contingent Liabilities ratio of INDO US BIOTECH is ₹0.98 Cr based on Mar2024 Standalone results.
Year Contingent Liabilities
Mar2024₹0.98 Cr
Mar2023₹0.95 Cr
Mar2022₹0.67 Cr
Mar2021₹0.59 Cr
Mar2020-

How is Contingent Liabilities of INDO US BIOTECH Trending?

Years Contingent Liabilities % Change
Mar2024 ₹0.98 Cr
2.84
Mar2023 ₹0.95 Cr
42.64
Mar2022 ₹0.67 Cr
13.27
Mar2021 ₹0.59 Cr
0
Mar2020 - -

Compare Contingent Liabilities of peers of INDO US BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDO US BIOTECH ₹308.6 Cr -3.6% 3.7% -19.6% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹12,934.7 Cr -4.3% -4.8% 17.2% Stock Analytics
KAVERI SEED COMPANY ₹6,436.8 Cr -4.4% -9.7% 36.7% Stock Analytics
VENKYS (INDIA) ₹2,264.3 Cr -1.7% -0.5% -13.9% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,435.5 Cr -4.3% -6.5% -30.7% Stock Analytics
MANGALAM GLOBAL ENTERPRISE ₹481.8 Cr -3.4% 12.2% NA Stock Analytics


INDO US BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
INDO US BIOTECH

-3.6%

3.7%

-19.6%

SENSEX

1.6%

1%

7%


You may also like the below Video Courses